TIP
BPMC

Torray Investment Partners’s Blueprint Medicines BPMC Stock Holding History

Torray Investment Partners’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,615
Closed -$2.13M – 101
2025
Q2 		$2.13M Sell
16,615
-64
-0.4% -$6.65K 0.31% 59
2025
Q1 		$1.48M Buy
16,679
+180
+1% +$17.6K 0.22% 74
2024
Q4 		$1.44M Buy
16,499
+186
+1% +$17K 0.21% 80
2024
Q3 		$1.51M Buy
16,313
+71
+0.4% +$7.05K 0.21% 80
2024
Q2 		$1.75M Sell
16,242
-3,178
-16% -$318K 0.26% 72
2024
Q1 		$1.84M Buy
19,420
+185
+1% +$15.9K 0.28% 68
2023
Q4 		$1.77M Sell
19,235
-5,556
-22% -$360K 0.29% 68
2023
Q3 		$1.25M Buy
24,791
+1,051
+4% +$56.2K 0.22% 80
2023
Q2 		$1.5M Buy
23,740
+137
+0.6% +$7.45K 0.26% 74
2023
Q1 		$1.06M Buy
23,603
+167
+0.7% +$7.52K 0.19% 86
2022
Q4 		$1.03M Buy
23,436
+5,949
+34% +$285K 0.18% 88
2022
Q3 		$1.15M Buy
17,487
+2,323
+15% +$149K 0.23% 81
2022
Q2 		$766K Buy
15,164
+2,675
+21% +$157K 0.15% 94
2022
Q1 		$798K Buy
12,489
+919
+8% +$66K 0.13% 95
2021
Q4 		$1.24M Sell
11,570
-4,368
-27% -$457K 0.18% 91
2021
Q3 		$1.64M Buy
15,938
+4,089
+35% +$381K 0.25% 85
2021
Q2 		$1.04M Buy
11,849
+343
+3% +$31.4K 0.15% 97
2021
Q1 		$1.12M Buy
+11,506
New +$1.15M 0.18% 97

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Torray Investment Partners's BPMC Position: Q3 2025 in Review

Torray Investment Partners sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 16,615 shares — an estimated $2.13M sold.

Torray Investment Partners first reported a position in BPMC in Q1 2021 and held it in 18 quarters. The position peaked at $2.13M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Torray Investment Partners reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Torray Investment Partners sold 16,615 Blueprint Medicines shares in Q3 2025, an estimated $2.13M.
  • Torray Investment Partners first reported a position in Blueprint Medicines in Q1 2021 and held it in 18 quarters.
  • Torray Investment Partners's Blueprint Medicines position peaked at $2.13M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Torray Investment Partners's 13F filing for Q3 2025, filed 22 Oct 2025.